Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7020903rdf:typepubmed:Citationlld:pubmed
pubmed-article:7020903lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C0025241lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:7020903lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:7020903pubmed:issue5lld:pubmed
pubmed-article:7020903pubmed:dateCreated1981-10-25lld:pubmed
pubmed-article:7020903pubmed:abstractTextThe results of a national clinical trial to compare combination and sequential chemotherapy for stage III or IV ovarian cancer are reported. Of the 253 patients from 16 centres across Canada who were admitted to the trial 13 were excluded from the analysis. All the patients were observed for 2 to 5 years from entry into the trial. There were no differences in response to therapy or in survival between the patients treated with melphalan followed by 5-fluorouracil and then by methotrexate in high dosage and the patients treated with the same agents in combination. Patients with minimal residual disease after resection of stage III ovarian cancer had a good prognosis. Other favourable prognostic factors were age (less than 55 years), performance status (90% or 100% on the Karnofsky scale) and histologic grade of the tumour.lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:languageenglld:pubmed
pubmed-article:7020903pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7020903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7020903pubmed:statusMEDLINElld:pubmed
pubmed-article:7020903pubmed:monthSeplld:pubmed
pubmed-article:7020903pubmed:issn0008-4409lld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:LevittMMlld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:WallCClld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:KirkM EMElld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:MillerA BABlld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:BoyesD ADAlld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:KlaassenD JDJlld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:PearsonJ GJGlld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:GerulathAAlld:pubmed
pubmed-article:7020903pubmed:authorpubmed-author:DoddsD JDJlld:pubmed
pubmed-article:7020903pubmed:issnTypePrintlld:pubmed
pubmed-article:7020903pubmed:day6lld:pubmed
pubmed-article:7020903pubmed:volume123lld:pubmed
pubmed-article:7020903pubmed:ownerNLMlld:pubmed
pubmed-article:7020903pubmed:authorsCompleteYlld:pubmed
pubmed-article:7020903pubmed:pagination365-71lld:pubmed
pubmed-article:7020903pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:meshHeadingpubmed-meshheading:7020903-...lld:pubmed
pubmed-article:7020903pubmed:year1980lld:pubmed
pubmed-article:7020903pubmed:articleTitleCombination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.lld:pubmed
pubmed-article:7020903pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7020903pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7020903pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7020903pubmed:publicationTypeControlled Clinical Triallld:pubmed